Bortezomib monotherapy for relapsed multiple myeloma

  • Technology appraisal guidance
  • TA129
  • Published: 
Download guidance (PDF)

Update information

March 2014: Implementation section updated to clarify that bortezomib monotherapy is recommended as an option for treating relapsed multiple myeloma.

ISBN: 978-1-4731-7071-1